A practical guide for finance leaders in pharmaceutical and chemical organizations who want faster insight, stronger margins, and better decisions.
Pharma CFOs operate at the center of complexity. Supply chain volatility, long investment cycles, pricing pressure, and growing ESG expectations make traditional finance processes too slow and too fragmented.
This whitepaper shows how leading finance teams integrate close and planning on a single foundation to move from reporting results to actively steering performance.
What you will learn
In this whitepaper, you will discover
- Where automation delivers the biggest impact in close and consolidation
- How to create one end‑to‑end planning view from demand to EBIT
- How to make uncertainty visible and measurable across the business
- How predictive intelligence supports real what‑if decisions
- How ESG data connects directly to cost, margin, and capital allocation
All insights are based on real projects with chemical and pharmaceutical organizations.
Who should read this
This whitepaper is designed for
- CFOs and finance leaders in pharma and chemicals
- Heads of controlling, FP&A, and consolidation
- Finance transformation and digital finance leaders
Turn finance into a true steering function.
Download the whitepaper to learn how integrated close and planning help pharma CFOs act faster, reduce risk, and protect profitability.
